Chapter 11: Peri-Arrest Arrhythmias Flashcards

1
Q

If a patient has a tachyarrhythmia with adverse features (unstable and at risk of deterioration), what do you do?

A
  1. Synchronised Cardioversion
  2. Amiodarone 300mg IV (if not responding) over 10-20 mins then 900mg infusion over 24hr
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does a synchronised cardioverter synchronise the shock with?

A
  1. The R wave

An unsynchronised shock can coincide with the t wave and cause VF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What energy to use for synchronised cardioversion of - Broad-complex tachyarrhymthia, AF & atrial flutter:

A
  1. Broad complex tachycardia - 120-150J and then increase
  2. Atrial flutter - 70-120J and increase as req.
  3. AF - max output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If a patient has a broad complex tachyarrhythmia with adverse features, what do you do?

A
  1. Synchronised cardioversion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If a patient has a broad complex tachyarrhythmia without adverse features that is regular, what do you do?

A
  1. May be VT or SVT + BBB

If VT - amiodarone 300mg IV over 20-60 mins then 900mg over 24hr

If SVT + BBB - Rx as regular narrow complex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If a patient has an irregular broad complex tachycardia and is stable, what could it be and what do you do?

A
  1. AF with BBB - Rx as for narrow complex tachy
  2. Pre-excited AF - consider Amiodarone
  3. Polymorphic VT - Call for expert help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you treat torsades du pointes?

A
  1. Stop drugs that prolong QT
  2. Correct electrolytes - esp. hypoK
  3. MgSO4 2g IV over 10 mins
  4. Get expert help!
  5. If adverse features - synchronised cardioversion
  6. If pulseless - defibrillation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are patients with regular narrow complex tachycardias without adverse features treated?

A
  1. Vagal manoeuvre
  2. Adenosine 6mg > 12mg > 12mg
  3. Monitor ECG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What adverse features would warrant synchronised cardioversion in tachyarrhythmia?

A
  1. Shock
  2. Syncope
  3. MI
  4. HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If a regular narrow complex tachycardia doesn’t respond to adenosine, what should be done?

A
  1. Control rate with BB - possible atrial flutter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a patient has an irregular narrow complex tachycardia but no adverse features, what should be done?

A
  1. Rate control - BB or diltiazem (digoxin if HF)
  2. Assess thromboembolic risk and consider anticoagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can be given for a regular narrow complex tachy if adenosine is CI or fails to terminate?

A
  1. Verapamil 2.5-5mg IV over 2 mins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If a patient has a very rapid narrow complex tachy to the point a pulse is impalpable what should you do?

A
  1. Synchonised DC cardiovert

Exception to normal as PEA is non-shockable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

If a patient has had AF for >48hr what should you do?

A
  1. Rate control
  2. Anticoagulant prophylaxis for 3wk before cardioversion
  3. Can do echo to R/O atrial thrombi and then cardiovert if req.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What should be done in patients with AF >48 hrs with urgent need for cardioversion?

A
  1. LMW heparin in therapeutic dose or IV bolus unfractionated heparin
  2. Maintain APTT 1.5-2x reference
  3. Continue heparin Rx
  4. Cardiovert pt.
  5. Start oral anticoagulation Rx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What agents can be used for chemical cardioversion of AF?

A
  1. Flecainide
  2. Propafenone
  3. CI - then use amiodarone 300mg 20-60min then 900mg over 24hr

CI in HF, LV impairment, IHD or prolonged QT

17
Q

What can cause bradyarrhythmia?

A
  1. Physiological - athletes, during sleep
  2. Cardiac - heart block, sinus node disease
  3. Non-cardiac - vasovagal, hypothermia, hypothyroid, hyperK
  4. Drug - Amiodarone, Beta blocker, Diltiazem, Digoxin,
18
Q

If a patient with bradyarrhythmia has adverse features, what is the management?

A
  1. Atropine 500mcg IV - repeat up to total 3mg dose (6 doses)
19
Q

If atropine doesn’t resolve a bradyarrhythmia with adverse features, what can be done?

A
  1. Transcutaneous pacing OR
  2. Isoprenaline 5mcg/min IV
  3. Adrenaline 2-10mcg/min IV
20
Q

What alternative drugs can be considered for bradyarrhythmia?

A
  1. Aminophylline 100-200mg slow IV infusion - due to acute inferior MI, spinal cord injury or cardiac transplant
  2. Dopamine 2.5-10mcg/min
  3. Glucagon - if caused by beta blocker or Ca2+ blocker
  4. Glycopyrrolate - instead of atropine
21
Q

What should be done if a patient with bradyarrhythmia is displaying no adverse features?

A
  1. Assess for risk of asystole:
    - Recent asystole
    - Mobitz II
    - Complete heart block with broad QRS
    - Ventricular pause >3s
  2. If risk - Atropine or transcutaneous pacing or adrenaline
  3. If no risk - continue observations
22
Q

When should you not give atropine

A
  1. Cardiac transplants - hearts denervated so don’t respond to vagal blockade
  2. May lead to paradoxical sinus arrest or high grade AV block
23
Q

When is transcutaneous pacing used for bradycardia?

A
  1. No response to Atropine or CI
  2. Not due to beta blocker/ca2+ blocker - glucagon
  3. Not due to digoxin - digoxin antibody

Should be initiated immediately if indicated

24
Q

When is temporary transvenous pacing considered?

A
  1. Documented recent asystole
  2. Mobitz type II
  3. Complete AV block